Allogene Therapeutics ALLO
NASDAQ ALLO
$1.54 -0.06 (-3.75%)
At close: Oct 1, 2026 · 4:00 PM EDT

Allogene Therapeutics (ALLO) Depreciation & Amortization (CF) (2018 - 2026)

Updated

Allogene Therapeutics (ALLO) reported Depreciation & Amortization (CF) of $2.65 million for Q2 2026, down 14.8% from $3.11 million a year earlier and down 7.8% from the prior quarter.

Analysis

Allogene Therapeutics (ALLO) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Allogene Therapeutics' Depreciation & Amortization (CF) came in at $11.71 million, down 7.4% year-over-year; for FY2025, it was $12.4 million, down 9.1% from FY2024.

  • Depreciation & Amortization (CF) has declined for three consecutive years, though with a five-year compound annual growth rate of 10.8% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $13.64 million in FY2024 (-4.0%), $14.2 million in FY2023 (-0.7%), $14.3 million in FY2022 (+36.7%) and $10.45 million in FY2021 (+40.6%).
  • The Q2 2026 figure ranks as the lowest quarterly Depreciation & Amortization (CF) since Q3 2021.
  • Year over year, Depreciation & Amortization (CF) has now declined in each of the last eight quarters, with an average decline of 9.3% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q4 2021 (growth of 130.0%); the low point was Q4 2022 (a decline of 27.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $2.87 million (Q1 2026), $3.1 million (Q4 2025) and $3.1 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Allogene Therapeutics 552.55 Mn 552.55 Mn - 2.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.65 Mn
Mar 31, 2026 2.87 Mn
Dec 31, 2025 3.10 Mn
Sep 30, 2025 3.10 Mn
Jun 30, 2025 3.11 Mn
Mar 31, 2025 3.10 Mn
Dec 31, 2024 3.23 Mn
Sep 30, 2024 3.21 Mn
Jun 30, 2024 3.64 Mn
Mar 31, 2024 3.56 Mn
Dec 31, 2023 3.48 Mn
Sep 30, 2023 3.57 Mn
Jun 30, 2023 3.64 Mn
Mar 31, 2023 3.51 Mn
Dec 31, 2022 3.07 Mn
Sep 30, 2022 3.86 Mn
Jun 30, 2022 3.68 Mn
Mar 31, 2022 3.69 Mn
Dec 31, 2021 4.24 Mn
Sep 30, 2021 2.33 Mn
API Access

Allogene Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ALLO&period=max&api_key=YOUR_API_KEY